Paul Hastings LLP has advised Ligand Pharmaceuticals Incorporated in connection with its private placement. Ligand Pharmaceuticals Incorporated has completed a private placement of $700 million aggregate…
Ligand Pharmaceuticals Completes $700 Million Convertible Senior Notes Private Placement
